Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amicus Therapeutics (NQ: FOLD ) 10.71 -0.01 (-0.09%) Official Closing Price Updated: 4:15 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amicus Therapeutics < Previous 1 2 3 4 5 Next > Looking Into Amicus Therapeutics's Return On Capital Employed June 07, 2021 During Q1, Amicus Therapeutics (NASDAQ:FOLD) brought in sales totaling $66.40 million. However, earnings decreased 18.31%, resulting in a loss of $52.58 million. In Q4, Amicus... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 27, 2021 Gainers Cellect Biotechnology (NASDAQ:APOP Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2021 May 27, 2021 Upgrades Craig-Hallum upgraded the previous rating for NVIDIA Corp (NASDAQ:NVDA) from Hold to Buy. In the first quarter, NVIDIA showed an EPS of $3.66, compared to $1.80... Via Benzinga Earnings Scheduled For May 10, 2021 May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... Via Benzinga The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing May 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:... Via Benzinga Amicus Therapeutics Inc (FOLD) Q1 2021 Earnings Call Transcript May 10, 2021 FOLD earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Amicus Therapeutics Q1 Earnings May 10, 2021 Shares of Amicus Therapeutics (NASDAQ:FOLD) rose 0.6% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 28.57% over... Via Benzinga Amicus Therapeutics Concludes Pre-BLA Meeting With FDA For AT-GAA In Pompe Disease May 03, 2021 Amicus Therapeutics Inc (NASDAQ: FOLD) has completed a Type B Pre-Biologics License Application (BLA) meeting with the FDA for AT-GAA (cipaglucosidase alfa co... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal May 25, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... Via Benzinga Why Amicus Therapeutics Stock Is Soaring Today April 14, 2021 Investors cheered an analyst's upgrade of the biotech stock. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021 May 21, 2021 Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,... Via Benzinga The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021 April 14, 2021 Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.